rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Cerenome, Inc.

CNSY · Nasdaq

Health CareMedical DevicesNot moving yet

CNSY stood above a rising 150-day average in 3 of the last 52 weekly readings, and has been out of that trend for the last 40 weeks. It is 59.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 40
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$10K
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
20 (+19)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 3 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$52KNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months0
Buyers · sellers1 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders20+19 on the quarter
New · exited19 · 0
Reported value$2.6M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
VANGUARD CAPITAL MANAGEMENT LLCnew · filed 13 Aug 2026304,745$1.3M+304,745
BlackRock, Inc.new · filed 7 Aug 202695,983$419K+95,983
GEODE CAPITAL MANAGEMENT, LLCnew · filed 12 Aug 202676,155$333K+76,155
VANGUARD FIDUCIARY TRUST COnew · filed 13 Aug 202636,868$161K+36,868
Ashton Thomas Private Wealth, LLCnew · filed 29 Jul 202634,306$150K+34,306
CITADEL ADVISORS LLCnew · filed 14 Aug 202625,597$112K+25,597
NORTHERN TRUST CORPnew · filed 13 Aug 202615,516$68K+15,516
WELLS FARGO & COMPANYnew · filed 14 Aug 20266,156$27K+6,156
Vanguard Global Advisers, LLCnew · filed 13 Aug 20262,282$9,972+2,282
OSAIC HOLDINGS, INC.new · filed 14 Aug 20262,000$8,740+2,000

Everyone who traded it

An van Es-Johansson Company insiderDirector · last 1 Oct 20260 · 0
Andrew John Hugh MacIntyre Sims Company insiderChief Financial Officer · last 1 Oct 20269 · 0
Howard Clowes Company insiderDirector · last 1 Oct 20267 · 0
Kyle Guse Company insiderDirector · last 1 Oct 20260 · 0
Marc H. Hedrick Company insiderChief Executive Officer · last 1 Oct 202630 · 1
Richard J. Hawkins Company insiderDirector · last 1 Oct 20264 · 0
Ronald Asbury Andrews Company insiderDirector · last 1 Oct 20260 · 0
Eric Joseph Daniels Company insiderChief Development Officer · last 20 Apr 20260 · 0
Robert P. Lenk Company insiderDirector · last 22 Aug 202512 · 1
Greg Petersen Company insiderDirector · last 18 Feb 20257 · 0
Norman D. Lafrance Company insiderChief Medical Officer · last 22 Feb 20240 · 0
Tiago Girao Company insiderVP & Chief Financial Officer · last 25 Jul 20183 · 0

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%
PLSE Pulse BiosciencesLeading+33%
INFU InfuSystems HoldingsLeading+27%
SMTI Sanara MedTechLeading+26%
ITGR Integer HoldingsLeading+23%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-293%
Free cash flow marginFY 2025 · to 31 Dec 2025-400%
Research spendFY 2025 · to 31 Dec 2025161%
Share count trendFY 2025 · to 10 Mar 202623.7%
Cash and equivalentsFY 2025 · to 31 Dec 2025$4.3M
Free cash flowFY 2025 · to 31 Dec 2025−$20.8M

Analyst forecasts

No analyst forecasts yet.